Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Living with Dementia

cinnamon1 - slowed movement1 - good sleep habits1 - korsakoff amnesic syndrome1 - antihypertensive drugs1 - stepfamily1 - parkinson’s disease2 - verbal fluency1 - immune globulin1 - terminal cognitive failure1 - amyloid-β1 - heart health risk1 - dopamine-producing nerve cells1 - autism spectrum disorder1 - movement disorders1 - treatment of alzheimer's1 - motor symptoms1 - advanced dementia1 - mayo clinic1 - psychomotor retardation1 - impaired memory1 - prostate cancer1 - memory problems3 - tetrahydrocannabinol1 - alzheimer's patient1 - apoplectic dementia1 - morphometry1 - amnesia1 - alcoholic encephalopathy10 - vci1 -